経鼻薬物送達技術 - 世界市場シェアとランキング、全体売上高と需要予測 2024-2030Nasal Drug Delivery Technology - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 経鼻薬物送達技術の世界市場は、2023年に5億4530万米ドルと推定され、2024-2030年の予測期間中のCAGRは4.5%で、2030年には7億4420万米ドルの再調整規模になると予測されている。 世界の医薬品市場は2022年に1,47... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリー経鼻薬物送達技術の世界市場は、2023年に5億4530万米ドルと推定され、2024-2030年の予測期間中のCAGRは4.5%で、2030年には7億4420万米ドルの再調整規模になると予測されている。世界の医薬品市場は2022年に1,475億米ドルとなり、今後6年間のCAGRは5%で成長する。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物製剤については、2022年には3810億米ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要としている患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の流行はワクチン開発とサプライチェーン・マネジメントの重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。 レポートの範囲 本レポートは、経鼻薬物送達技術の世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別の分析とともに、総売上高、主要企業の市場シェア、ランキングに焦点を当てています。 経鼻薬物送達技術の市場規模、推計、予測は、2023年を基準年として、2019年から2030年までの期間の履歴データと予測データを売上高(百万ドル)で提供します。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、経鼻薬物送達技術に関する情報に基づいたビジネス上の意思決定を行うのに役立ちます。 市場区分 企業別 3M 米国 Aegis Therapeutics LLC アプターグループ ベクトン・ディッキンソン・アンド・カンパニー BFアッシャー&カンパニー カディラ・ファーマシューティカルズ・リミテッド ディッキンソン アンド カンパニー ダグラス・ファーマシューティカルズ ENT Technologies Pty.Ltd. グラクソスミスクラインPLC ジョンソン・エンド・ジョンソン メルク社 ノバルティスAG オプティノーズ ペンドファーム社 ファイザー プロミウス・ファーマ 新日本バイオメディカル研究所 タイプ別セグメント 加圧タイプ 非加圧タイプ 用途別セグメント 鼻づまり 鼻炎 喘息 その他 地域別 北米 米国 カナダ 欧州 ドイツ フランス イギリス イタリア ロシア アジア太平洋 中国 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 各章の概要 第1章:報告書のスコープ、世界の総市場規模を紹介します。また、市場ダイナミクス、市場の最新動向、市場の促進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章 経鼻薬物送達技術メーカーの競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析します。 第3章:各種市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展可能性を網羅し、読者が各市場セグメントにおけるブルーオーシャン市場を見つけやすくします。 第4章:用途別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのを助ける。 第5章:地域レベルでの経鼻薬物送達技術の収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場スペース、市場規模を紹介しています。 第6章:経鼻薬物送達技術の国別収益。各国・地域のタイプ別、用途別のシグメイトデータを提供しています。 第7章:主要企業のプロファイルを提供し、製品収益、売上総利益率、製品紹介、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介します。 第8章:産業の上流と下流を含む産業チェーンの分析。 第9章:結論 目次1 Market Overview1.1 Nasal Drug Delivery Technology Product Introduction 1.2 Global Nasal Drug Delivery Technology Market Size Forecast 1.3 Nasal Drug Delivery Technology Market Trends & Drivers 1.3.1 Nasal Drug Delivery Technology Industry Trends 1.3.2 Nasal Drug Delivery Technology Market Drivers & Opportunity 1.3.3 Nasal Drug Delivery Technology Market Challenges 1.3.4 Nasal Drug Delivery Technology Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Nasal Drug Delivery Technology Players Revenue Ranking (2023) 2.2 Global Nasal Drug Delivery Technology Revenue by Company (2019-2024) 2.3 Key Companies Nasal Drug Delivery Technology Manufacturing Base Distribution and Headquarters 2.4 Key Companies Nasal Drug Delivery Technology Product Offered 2.5 Key Companies Time to Begin Mass Production of Nasal Drug Delivery Technology 2.6 Nasal Drug Delivery Technology Market Competitive Analysis 2.6.1 Nasal Drug Delivery Technology Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Nasal Drug Delivery Technology Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Drug Delivery Technology as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Pressurized Type 3.1.2 Non-pressurized Type 3.2 Global Nasal Drug Delivery Technology Sales Value by Type 3.2.1 Global Nasal Drug Delivery Technology Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Nasal Drug Delivery Technology Sales Value, by Type (2019-2030) 3.2.3 Global Nasal Drug Delivery Technology Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Nasal Congestion 4.1.2 Rhinitis 4.1.3 Asthma 4.1.4 Other 4.2 Global Nasal Drug Delivery Technology Sales Value by Application 4.2.1 Global Nasal Drug Delivery Technology Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Nasal Drug Delivery Technology Sales Value, by Application (2019-2030) 4.2.3 Global Nasal Drug Delivery Technology Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Nasal Drug Delivery Technology Sales Value by Region 5.1.1 Global Nasal Drug Delivery Technology Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Nasal Drug Delivery Technology Sales Value by Region (2019-2024) 5.1.3 Global Nasal Drug Delivery Technology Sales Value by Region (2025-2030) 5.1.4 Global Nasal Drug Delivery Technology Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Nasal Drug Delivery Technology Sales Value, 2019-2030 5.2.2 North America Nasal Drug Delivery Technology Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Nasal Drug Delivery Technology Sales Value, 2019-2030 5.3.2 Europe Nasal Drug Delivery Technology Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Nasal Drug Delivery Technology Sales Value, 2019-2030 5.4.2 Asia Pacific Nasal Drug Delivery Technology Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Nasal Drug Delivery Technology Sales Value, 2019-2030 5.5.2 South America Nasal Drug Delivery Technology Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Nasal Drug Delivery Technology Sales Value, 2019-2030 5.6.2 Middle East & Africa Nasal Drug Delivery Technology Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Nasal Drug Delivery Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Nasal Drug Delivery Technology Sales Value 6.3 United States 6.3.1 United States Nasal Drug Delivery Technology Sales Value, 2019-2030 6.3.2 United States Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Nasal Drug Delivery Technology Sales Value, 2019-2030 6.4.2 Europe Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Nasal Drug Delivery Technology Sales Value, 2019-2030 6.5.2 China Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.5.3 China Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Nasal Drug Delivery Technology Sales Value, 2019-2030 6.6.2 Japan Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Nasal Drug Delivery Technology Sales Value, 2019-2030 6.7.2 South Korea Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Nasal Drug Delivery Technology Sales Value, 2019-2030 6.8.2 Southeast Asia Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Nasal Drug Delivery Technology Sales Value, 2019-2030 6.9.2 India Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.9.3 India Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 3M United States 7.1.1 3M United States Profile 7.1.2 3M United States Main Business 7.1.3 3M United States Nasal Drug Delivery Technology Products, Services and Solutions 7.1.4 3M United States Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.1.5 3M United States Recent Developments 7.2 Aegis Therapeutics LLC 7.2.1 Aegis Therapeutics LLC Profile 7.2.2 Aegis Therapeutics LLC Main Business 7.2.3 Aegis Therapeutics LLC Nasal Drug Delivery Technology Products, Services and Solutions 7.2.4 Aegis Therapeutics LLC Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.2.5 Aegis Therapeutics LLC Recent Developments 7.3 Aptargroup, Inc. 7.3.1 Aptargroup, Inc. Profile 7.3.2 Aptargroup, Inc. Main Business 7.3.3 Aptargroup, Inc. Nasal Drug Delivery Technology Products, Services and Solutions 7.3.4 Aptargroup, Inc. Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.3.5 Becton, Dickinson and Company Recent Developments 7.4 Becton, Dickinson and Company 7.4.1 Becton, Dickinson and Company Profile 7.4.2 Becton, Dickinson and Company Main Business 7.4.3 Becton, Dickinson and Company Nasal Drug Delivery Technology Products, Services and Solutions 7.4.4 Becton, Dickinson and Company Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.4.5 Becton, Dickinson and Company Recent Developments 7.5 BF Ascher & Company, Inc. 7.5.1 BF Ascher & Company, Inc. Profile 7.5.2 BF Ascher & Company, Inc. Main Business 7.5.3 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Products, Services and Solutions 7.5.4 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.5.5 BF Ascher & Company, Inc. Recent Developments 7.6 Cadila Pharmaceuticals Ltd 7.6.1 Cadila Pharmaceuticals Ltd Profile 7.6.2 Cadila Pharmaceuticals Ltd Main Business 7.6.3 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Products, Services and Solutions 7.6.4 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.6.5 Cadila Pharmaceuticals Ltd Recent Developments 7.7 Dickinson and Company 7.7.1 Dickinson and Company Profile 7.7.2 Dickinson and Company Main Business 7.7.3 Dickinson and Company Nasal Drug Delivery Technology Products, Services and Solutions 7.7.4 Dickinson and Company Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.7.5 Dickinson and Company Recent Developments 7.8 Douglas Pharmaceuticals Ltd 7.8.1 Douglas Pharmaceuticals Ltd Profile 7.8.2 Douglas Pharmaceuticals Ltd Main Business 7.8.3 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Products, Services and Solutions 7.8.4 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.8.5 Douglas Pharmaceuticals Ltd Recent Developments 7.9 ENT Technologies Pty. Ltd 7.9.1 ENT Technologies Pty. Ltd Profile 7.9.2 ENT Technologies Pty. Ltd Main Business 7.9.3 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Products, Services and Solutions 7.9.4 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.9.5 ENT Technologies Pty. Ltd Recent Developments 7.10 Glaxosmithkline PLC 7.10.1 Glaxosmithkline PLC Profile 7.10.2 Glaxosmithkline PLC Main Business 7.10.3 Glaxosmithkline PLC Nasal Drug Delivery Technology Products, Services and Solutions 7.10.4 Glaxosmithkline PLC Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.10.5 Glaxosmithkline PLC Recent Developments 7.11 Johnson & Johnson 7.11.1 Johnson & Johnson Profile 7.11.2 Johnson & Johnson Main Business 7.11.3 Johnson & Johnson Nasal Drug Delivery Technology Products, Services and Solutions 7.11.4 Johnson & Johnson Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.11.5 Johnson & Johnson Recent Developments 7.12 Merck & Co., Inc. 7.12.1 Merck & Co., Inc. Profile 7.12.2 Merck & Co., Inc. Main Business 7.12.3 Merck & Co., Inc. Nasal Drug Delivery Technology Products, Services and Solutions 7.12.4 Merck & Co., Inc. Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.12.5 Merck & Co., Inc. Recent Developments 7.13 Novartis AG 7.13.1 Novartis AG Profile 7.13.2 Novartis AG Main Business 7.13.3 Novartis AG Nasal Drug Delivery Technology Products, Services and Solutions 7.13.4 Novartis AG Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.13.5 Novartis AG Recent Developments 7.14 OptiNose, Inc 7.14.1 OptiNose, Inc Profile 7.14.2 OptiNose, Inc Main Business 7.14.3 OptiNose, Inc Nasal Drug Delivery Technology Products, Services and Solutions 7.14.4 OptiNose, Inc Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.14.5 OptiNose, Inc Recent Developments 7.15 PendoPharm, Inc 7.15.1 PendoPharm, Inc Profile 7.15.2 PendoPharm, Inc Main Business 7.15.3 PendoPharm, Inc Nasal Drug Delivery Technology Products, Services and Solutions 7.15.4 PendoPharm, Inc Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.15.5 PendoPharm, Inc Recent Developments 7.16 Pfizer, Inc 7.16.1 Pfizer, Inc Profile 7.16.2 Pfizer, Inc Main Business 7.16.3 Pfizer, Inc Nasal Drug Delivery Technology Products, Services and Solutions 7.16.4 Pfizer, Inc Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.16.5 Pfizer, Inc Recent Developments 7.17 Promius Pharma, LLC 7.17.1 Promius Pharma, LLC Profile 7.17.2 Promius Pharma, LLC Main Business 7.17.3 Promius Pharma, LLC Nasal Drug Delivery Technology Products, Services and Solutions 7.17.4 Promius Pharma, LLC Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.17.5 Promius Pharma, LLC Recent Developments 7.18 Shin Nippon Biomedical Laboratories 7.18.1 Shin Nippon Biomedical Laboratories Profile 7.18.2 Shin Nippon Biomedical Laboratories Main Business 7.18.3 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Products, Services and Solutions 7.18.4 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.18.5 Shin Nippon Biomedical Laboratories Recent Developments 8 Industry Chain Analysis 8.1 Nasal Drug Delivery Technology Industrial Chain 8.2 Nasal Drug Delivery Technology Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Nasal Drug Delivery Technology Sales Model 8.5.2 Sales Channel 8.5.3 Nasal Drug Delivery Technology Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Nasal Drug Delivery Technology was estimated to be worth US$ 54530 million in 2023 and is forecast to a readjusted size of US$ 74420 million by 2030 with a CAGR of 4.5% during the forecast period 2024-2030 Table of Contents1 Market Overview1.1 Nasal Drug Delivery Technology Product Introduction 1.2 Global Nasal Drug Delivery Technology Market Size Forecast 1.3 Nasal Drug Delivery Technology Market Trends & Drivers 1.3.1 Nasal Drug Delivery Technology Industry Trends 1.3.2 Nasal Drug Delivery Technology Market Drivers & Opportunity 1.3.3 Nasal Drug Delivery Technology Market Challenges 1.3.4 Nasal Drug Delivery Technology Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Nasal Drug Delivery Technology Players Revenue Ranking (2023) 2.2 Global Nasal Drug Delivery Technology Revenue by Company (2019-2024) 2.3 Key Companies Nasal Drug Delivery Technology Manufacturing Base Distribution and Headquarters 2.4 Key Companies Nasal Drug Delivery Technology Product Offered 2.5 Key Companies Time to Begin Mass Production of Nasal Drug Delivery Technology 2.6 Nasal Drug Delivery Technology Market Competitive Analysis 2.6.1 Nasal Drug Delivery Technology Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Nasal Drug Delivery Technology Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nasal Drug Delivery Technology as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Pressurized Type 3.1.2 Non-pressurized Type 3.2 Global Nasal Drug Delivery Technology Sales Value by Type 3.2.1 Global Nasal Drug Delivery Technology Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Nasal Drug Delivery Technology Sales Value, by Type (2019-2030) 3.2.3 Global Nasal Drug Delivery Technology Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Nasal Congestion 4.1.2 Rhinitis 4.1.3 Asthma 4.1.4 Other 4.2 Global Nasal Drug Delivery Technology Sales Value by Application 4.2.1 Global Nasal Drug Delivery Technology Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Nasal Drug Delivery Technology Sales Value, by Application (2019-2030) 4.2.3 Global Nasal Drug Delivery Technology Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Nasal Drug Delivery Technology Sales Value by Region 5.1.1 Global Nasal Drug Delivery Technology Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Nasal Drug Delivery Technology Sales Value by Region (2019-2024) 5.1.3 Global Nasal Drug Delivery Technology Sales Value by Region (2025-2030) 5.1.4 Global Nasal Drug Delivery Technology Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Nasal Drug Delivery Technology Sales Value, 2019-2030 5.2.2 North America Nasal Drug Delivery Technology Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Nasal Drug Delivery Technology Sales Value, 2019-2030 5.3.2 Europe Nasal Drug Delivery Technology Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Nasal Drug Delivery Technology Sales Value, 2019-2030 5.4.2 Asia Pacific Nasal Drug Delivery Technology Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Nasal Drug Delivery Technology Sales Value, 2019-2030 5.5.2 South America Nasal Drug Delivery Technology Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Nasal Drug Delivery Technology Sales Value, 2019-2030 5.6.2 Middle East & Africa Nasal Drug Delivery Technology Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Nasal Drug Delivery Technology Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Nasal Drug Delivery Technology Sales Value 6.3 United States 6.3.1 United States Nasal Drug Delivery Technology Sales Value, 2019-2030 6.3.2 United States Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Nasal Drug Delivery Technology Sales Value, 2019-2030 6.4.2 Europe Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Nasal Drug Delivery Technology Sales Value, 2019-2030 6.5.2 China Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.5.3 China Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Nasal Drug Delivery Technology Sales Value, 2019-2030 6.6.2 Japan Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Nasal Drug Delivery Technology Sales Value, 2019-2030 6.7.2 South Korea Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Nasal Drug Delivery Technology Sales Value, 2019-2030 6.8.2 Southeast Asia Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Nasal Drug Delivery Technology Sales Value, 2019-2030 6.9.2 India Nasal Drug Delivery Technology Sales Value by Type (%), 2023 VS 2030 6.9.3 India Nasal Drug Delivery Technology Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 3M United States 7.1.1 3M United States Profile 7.1.2 3M United States Main Business 7.1.3 3M United States Nasal Drug Delivery Technology Products, Services and Solutions 7.1.4 3M United States Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.1.5 3M United States Recent Developments 7.2 Aegis Therapeutics LLC 7.2.1 Aegis Therapeutics LLC Profile 7.2.2 Aegis Therapeutics LLC Main Business 7.2.3 Aegis Therapeutics LLC Nasal Drug Delivery Technology Products, Services and Solutions 7.2.4 Aegis Therapeutics LLC Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.2.5 Aegis Therapeutics LLC Recent Developments 7.3 Aptargroup, Inc. 7.3.1 Aptargroup, Inc. Profile 7.3.2 Aptargroup, Inc. Main Business 7.3.3 Aptargroup, Inc. Nasal Drug Delivery Technology Products, Services and Solutions 7.3.4 Aptargroup, Inc. Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.3.5 Becton, Dickinson and Company Recent Developments 7.4 Becton, Dickinson and Company 7.4.1 Becton, Dickinson and Company Profile 7.4.2 Becton, Dickinson and Company Main Business 7.4.3 Becton, Dickinson and Company Nasal Drug Delivery Technology Products, Services and Solutions 7.4.4 Becton, Dickinson and Company Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.4.5 Becton, Dickinson and Company Recent Developments 7.5 BF Ascher & Company, Inc. 7.5.1 BF Ascher & Company, Inc. Profile 7.5.2 BF Ascher & Company, Inc. Main Business 7.5.3 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Products, Services and Solutions 7.5.4 BF Ascher & Company, Inc. Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.5.5 BF Ascher & Company, Inc. Recent Developments 7.6 Cadila Pharmaceuticals Ltd 7.6.1 Cadila Pharmaceuticals Ltd Profile 7.6.2 Cadila Pharmaceuticals Ltd Main Business 7.6.3 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Products, Services and Solutions 7.6.4 Cadila Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.6.5 Cadila Pharmaceuticals Ltd Recent Developments 7.7 Dickinson and Company 7.7.1 Dickinson and Company Profile 7.7.2 Dickinson and Company Main Business 7.7.3 Dickinson and Company Nasal Drug Delivery Technology Products, Services and Solutions 7.7.4 Dickinson and Company Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.7.5 Dickinson and Company Recent Developments 7.8 Douglas Pharmaceuticals Ltd 7.8.1 Douglas Pharmaceuticals Ltd Profile 7.8.2 Douglas Pharmaceuticals Ltd Main Business 7.8.3 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Products, Services and Solutions 7.8.4 Douglas Pharmaceuticals Ltd Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.8.5 Douglas Pharmaceuticals Ltd Recent Developments 7.9 ENT Technologies Pty. Ltd 7.9.1 ENT Technologies Pty. Ltd Profile 7.9.2 ENT Technologies Pty. Ltd Main Business 7.9.3 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Products, Services and Solutions 7.9.4 ENT Technologies Pty. Ltd Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.9.5 ENT Technologies Pty. Ltd Recent Developments 7.10 Glaxosmithkline PLC 7.10.1 Glaxosmithkline PLC Profile 7.10.2 Glaxosmithkline PLC Main Business 7.10.3 Glaxosmithkline PLC Nasal Drug Delivery Technology Products, Services and Solutions 7.10.4 Glaxosmithkline PLC Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.10.5 Glaxosmithkline PLC Recent Developments 7.11 Johnson & Johnson 7.11.1 Johnson & Johnson Profile 7.11.2 Johnson & Johnson Main Business 7.11.3 Johnson & Johnson Nasal Drug Delivery Technology Products, Services and Solutions 7.11.4 Johnson & Johnson Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.11.5 Johnson & Johnson Recent Developments 7.12 Merck & Co., Inc. 7.12.1 Merck & Co., Inc. Profile 7.12.2 Merck & Co., Inc. Main Business 7.12.3 Merck & Co., Inc. Nasal Drug Delivery Technology Products, Services and Solutions 7.12.4 Merck & Co., Inc. Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.12.5 Merck & Co., Inc. Recent Developments 7.13 Novartis AG 7.13.1 Novartis AG Profile 7.13.2 Novartis AG Main Business 7.13.3 Novartis AG Nasal Drug Delivery Technology Products, Services and Solutions 7.13.4 Novartis AG Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.13.5 Novartis AG Recent Developments 7.14 OptiNose, Inc 7.14.1 OptiNose, Inc Profile 7.14.2 OptiNose, Inc Main Business 7.14.3 OptiNose, Inc Nasal Drug Delivery Technology Products, Services and Solutions 7.14.4 OptiNose, Inc Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.14.5 OptiNose, Inc Recent Developments 7.15 PendoPharm, Inc 7.15.1 PendoPharm, Inc Profile 7.15.2 PendoPharm, Inc Main Business 7.15.3 PendoPharm, Inc Nasal Drug Delivery Technology Products, Services and Solutions 7.15.4 PendoPharm, Inc Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.15.5 PendoPharm, Inc Recent Developments 7.16 Pfizer, Inc 7.16.1 Pfizer, Inc Profile 7.16.2 Pfizer, Inc Main Business 7.16.3 Pfizer, Inc Nasal Drug Delivery Technology Products, Services and Solutions 7.16.4 Pfizer, Inc Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.16.5 Pfizer, Inc Recent Developments 7.17 Promius Pharma, LLC 7.17.1 Promius Pharma, LLC Profile 7.17.2 Promius Pharma, LLC Main Business 7.17.3 Promius Pharma, LLC Nasal Drug Delivery Technology Products, Services and Solutions 7.17.4 Promius Pharma, LLC Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.17.5 Promius Pharma, LLC Recent Developments 7.18 Shin Nippon Biomedical Laboratories 7.18.1 Shin Nippon Biomedical Laboratories Profile 7.18.2 Shin Nippon Biomedical Laboratories Main Business 7.18.3 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Products, Services and Solutions 7.18.4 Shin Nippon Biomedical Laboratories Nasal Drug Delivery Technology Revenue (US$ Million) & (2019-2024) 7.18.5 Shin Nippon Biomedical Laboratories Recent Developments 8 Industry Chain Analysis 8.1 Nasal Drug Delivery Technology Industrial Chain 8.2 Nasal Drug Delivery Technology Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Nasal Drug Delivery Technology Sales Model 8.5.2 Sales Channel 8.5.3 Nasal Drug Delivery Technology Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|